Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 11:10:917731.
doi: 10.3389/fped.2022.917731. eCollection 2022.

Are infections in children with juvenile idiopathic arthritis more frequent than in healthy children? A prospective multicenter observational study

Affiliations

Are infections in children with juvenile idiopathic arthritis more frequent than in healthy children? A prospective multicenter observational study

Clara Udaondo et al. Front Pediatr. .

Abstract

Background: Children with juvenile idiopathic arthritis (JIA) might be at a higher risk of infection. Our objectives are to describe and compare infection rates in patients with JIA vs. healthy patients.

Methods: A prospective, multicenter observational study was performed in Spain from January 2017 to June 2019. Patients with JIA from 7 participating hospitals and children without JIA (siblings of patients with JIA, and non-JIA children from primary health centers) were followed up with quarterly questionnaires to record infection episodes. Tuberculosis, herpes zoster, and infections requiring hospital admission were considered severe infections. Rates of infection (episodes/patient/year) were compared using a generalized estimating equations model.

Results: A total of 371 children (181 with and 190 without JIA) were included. The median age was 8.8 years (IQR 5.5-11.3); 75% of the patients with JIA received immunosuppressive treatment (24% methotrexate, 22% biologic, 26% both). A total of 667 infections were recorded; 15 (2.2%) were considered severe. The infection rate was 1.31 (95%CI 1.1-1.5) in JIA and 1.12 (95%CI 0.9-1.3) in non-JIA participants (p = 0.19). Age <4 years increased the infection rate by 2.5 times (2.72 vs. 1.12, p < 0.001) in both groups. The most frequent infection sites were upper respiratory (62.6% vs. 74.5%) and gastrointestinal (18.8% vs. 11.4%). There were no differences in severe infections (2.5% vs. 2%, p = 0.65) between the groups. In children with JIA, younger age and higher disease activity (JADAS71) were associated with a higher infection rate.

Conclusion: We found no differences in the infection rate or infection severity between patients with and without JIA. Most infections were mild. An age younger than 4 years increased the infection risk in both groups. Higher disease activity was associated with a higher infection rate.

Keywords: infection rate; infections; juvenile idiopathic arthritis (JIA); methotrexate; safety; tumor necrosis alpha antagonist.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
(A) Infection rate (episodes/patient/year) in JIA vs. non-JIA. (B) Infection rate (episodes/patient/year) according to age bands in both groups. (C) Contour plot* - Multivariant analysis graph showing the correlation between infection rate in patients with JIA with age and disease activity (JADAS71). *A contour plot provides a two-dimensional view in which all points that have the same response are connected to produce contour lines of constant responses. A contour plot contains the following elements: (a) Predictors for infection rate, displayed on the x- (years) and y- (disease activity) axes. (b) Contour lines that connect points that have the same fitted response value. (c) Colored contour bands that represent ranges of the fitted response values (Means for response variables that contain counts that follow the Poisson distribution).

References

    1. Beukelman T, Xie F, Chen L, Baddley JW, Delzell E, Grijalva CG, et al. Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum. (2012) 64:2773–80. 10.1002/art.34458 - DOI - PMC - PubMed
    1. Toussi SS, Pan N, Walters HM, Walsh TJ. Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: Systematic review of the literature. Clin Infect Dis. (2013) 57:1318–30. 10.1093/cid/cit489 - DOI - PMC - PubMed
    1. Swart J, Giancane G, Horneff G, Magnusson B, Hofer M, Alexeeva E, et al. Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: Combined data of more than 15,000 patients from Pharmachild and national registries. Arthritis Res Ther. (2018) 20:285. 10.1186/s13075-018-1780-z - DOI - PMC - PubMed
    1. Nagy A, Mátrai P, Hegyi P, Alizadeh H, Bajor J, Czopf L, et al. The effects of TNF-alpha inhibitor therapy on the incidence of infection in JIA children: A meta-analysis. Pediatr Rheumatol. (2019) 17:4. 10.1186/s12969-019-0305-x - DOI - PMC - PubMed
    1. Becker I, Horneff G. Risk of serious infection in juvenile idiopathic arthritis patients associated with tumor necrosis factor inhibitors and disease activity in the German biologics in pediatric rheumatology registry. Arthritis Care Res. (2017) 69:552–60. 10.1002/acr.22961 - DOI - PubMed